SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing...
SEATTLE, Wash and VANCOUVER, British Columbia, Nov. 02, 2021 (GLOBE NEWSWIRE) -- -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a...
Phase 1 trial is underway with topline results expected in the first half of 2022 Represents Landos’ seventh IND cleared...
An Urgent Call to Support Healthcare Investment in Public-Private Initiatives Delegates at the second edition of ECAM – The European...
CODEX Brain Tissue Image CODEX staining of a human brain tissue sample reveals the presence of biomarkers that enable researchers...
Record Quarter: U.S. Net Revenue Grew 58% Year-over-Year to $26.7 Million$107.8 Million Cash Position at Quarter-EndInitiated Jeuveau® “Extra Strength” Phase...
Program Designed to Offer Consumers an “Extra Strength” Dosing OptionEvolus is Uniquely Positioned to Capitalize on this Opportunity with the...
MINNEAPOLIS, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Ikena expects to initiate its first-in-human phase 1 clinical trial in early 2022 in patients with solid tumors that harbor...
NEW YORK, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and...
Upcoming Phase 2 trial marks expansion of Galecto pipeline into oncology and provides opportunity for exploring the use of galectin-3...
As an element of Nautilus’ overall reagent development and sourcing strategy, the partnership aims to accelerate research and development, and...
SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision...
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company...
NEEDHAM, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a late clinical stage biopharmaceutical company developing...
Late-breaking oral presentation compares transplant-free survival in patients with PBC treated with OCA to external controls from the Global PBC...
GARDEN CITY, N.Y., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical...
SYDNEY, AUSTRALIA, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
Phase 1 Study in Mild COVID-19 Patients Demonstrated a Favorable Safety and Tolerability Profile and Statistically Significant Clinical Symptom and...
Lonza to acquire and operate Codiak's Lexington, MA (US) facility and become the strategic manufacturing partner for Codiak’s pipelineLonza and...
